Cell‐Surface labeling and internalization by a fluorescent inhibitor of prostate‐specific membrane antigen

Abstract

Our results suggest that potent, small-molecule inhibitors of PSMA can be utilized as carriers for targeted delivery for prostate cancer for future imaging and therapeutic applications.